Riociguat for the Treatment of Pulmonary Arterial Hypertension

This publication has 25 references indexed in Scilit:

• Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
  New England Journal of Medicine, 2013
• An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
  Chest, 2012
• Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials
  Circulation, 2012
• Mechanisms of disease: pulmonary arterial hypertension
  Nature Reviews Cardiology, 2011
• Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
  Circulation, 2011
• Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
  European Respiratory Journal, 2010
• Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
  European Heart Journal, 2009
• ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
  Circulation, 2009
• First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
  European Respiratory Journal, 2009
• Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension
  American Journal of Respiratory and Critical Care Medicine, 2000